1. Home
  2. LQDT vs NEO Comparison

LQDT vs NEO Comparison

Compare LQDT & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Liquidity Services Inc.

LQDT

Liquidity Services Inc.

HOLD

Current Price

$38.47

Market Cap

1.0B

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$13.95

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LQDT
NEO
Founded
1999
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Catalog/Specialty Distribution
Precision Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
2005
2008

Fundamental Metrics

Financial Performance
Metric
LQDT
NEO
Price
$38.47
$13.95
Analyst Decision
Buy
Strong Buy
Analyst Count
1
8
Target Price
$40.00
$13.38
AVG Volume (30 Days)
154.6K
2.9M
Earning Date
05-07-2026
04-28-2026
Dividend Yield
N/A
N/A
EPS Growth
38.10
N/A
EPS
0.46
N/A
Revenue
$476,669,000.00
N/A
Revenue This Year
N/A
$10.63
Revenue Next Year
N/A
$9.73
P/E Ratio
$82.91
N/A
Revenue Growth
31.20
N/A
52 Week Low
$21.67
$4.72
52 Week High
$39.55
$13.88

Technical Indicators

Market Signals
Indicator
LQDT
NEO
Relative Strength Index (RSI) 61.53 78.61
Support Level $30.06 $11.49
Resistance Level $38.63 N/A
Average True Range (ATR) 1.07 0.65
MACD 0.02 0.24
Stochastic Oscillator 70.85 94.98

Price Performance

Historical Comparison
LQDT
NEO

About LQDT Liquidity Services Inc.

Liquidity Services Inc is an online auction marketplace. It manages and sells inventory and equipment for business and government clients by operating a network of e-commerce marketplaces that enable buyers and sellers to transact in an efficient, automated environment offering across different product categories. The company has four reportable segments: GovDeals, Retail Supply Chain Group (RSCG), and Machinio & Software Solutions. It generates majority of its revenue from Retail Supply Chain Group (RSCG) segment which consists of marketplaces that enable corporations located in the United States and Canada to sell excess, returned, and overstocked consumer goods. Geographically, a substantial portion the company's revenue is generated from its business in United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. The company operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: